AE Wealth Management’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.3M | Sell |
5,875
-1,439
| -20% | -$923K | 0.02% | 508 |
|
|
2025
Q4 | $4.95M | Buy |
7,314
+243
| +3% | +$165K | 0.03% | 395 |
|
|
2025
Q3 | $4.52M | Sell |
7,071
-4,526
| -39% | -$2.75M | 0.03% | 386 |
|
|
2025
Q2 | $6.22M | Buy |
11,597
+5,692
| +96% | +$2.72M | 0.05% | 326 |
|
|
2025
Q1 | $2.48M | Sell |
5,905
-1,130
| -16% | -$491K | 0.02% | 473 |
|
|
2024
Q4 | $2.91M | Buy |
7,035
+686
| +11% | +$301K | 0.02% | 452 |
|
|
2024
Q3 | $3.21M | Sell |
6,349
-1,608
| -20% | -$781K | 0.03% | 423 |
|
|
2024
Q2 | $3.88M | Buy |
7,957
+1,134
| +17% | +$569K | 0.04% | 385 |
|
|
2024
Q1 | $3.68M | Sell |
6,823
-18,376
| -73% | -$10M | 0.04% | 361 |
|
|
2023
Q4 | $13.2M | Sell |
25,199
-1,602
| -6% | -$752K | 0.07% | 332 |
|
|
2023
Q3 | $11.7M | Buy |
26,801
+561
| +2% | +$280K | 0.07% | 341 |
|
|
2023
Q2 | $13.2M | Buy |
26,240
+587
| +2% | +$281K | 0.08% | 307 |
|
|
2023
Q1 | $12.8M | Buy |
25,653
+1,620
| +7% | +$775K | 0.08% | 291 |
|
|
2022
Q4 | $9.8M | Sell |
24,033
-467
| -2% | -$181K | 0.07% | 325 |
|
|
2022
Q3 | $7.98M | Buy |
24,500
+668
| +3% | +$245K | 0.06% | 326 |
|
|
2022
Q2 | $8.36M | Sell |
23,832
-646
| -3% | -$263K | 0.07% | 307 |
|
|
2022
Q1 | $13.4M | Sell |
24,478
-1,476
| -6% | -$776K | 0.09% | 229 |
|
|
2021
Q4 | $17.1M | Sell |
25,954
-2,603
| -9% | -$1.63M | 0.12% | 176 |
|
|
2021
Q3 | $17.8M | Sell |
28,557
-6,228
| -18% | -$4.18M | 0.15% | 153 |
|
|
2021
Q2 | $22M | Buy |
34,785
+1,556
| +5% | +$859K | 0.19% | 120 |
|
|
2021
Q1 | $16.3M | Buy |
33,229
+9,238
| +39% | +$4.63M | 0.16% | 133 |
|
|
2020
Q4 | $12M | Buy |
23,991
+7,200
| +43% | +$3.22M | 0.14% | 156 |
|
|
2020
Q3 | $6.6M | Buy |
16,791
+5,508
| +49% | +$2.04M | 0.09% | 194 |
|
|
2020
Q2 | $3.73M | Buy |
11,283
+6,521
| +137% | +$1.89M | 0.06% | 273 |
|
|
2020
Q1 | $1.15M | Buy |
4,762
+3,630
| +321% | +$947K | 0.03% | 445 |
|
|
2019
Q4 | $296K | Buy |
1,132
+29
| +3% | +$7.64K | 0.01% | 906 |
|
|
2019
Q3 | $300K | Sell |
1,103
-22
| -2% | -$6.12K | 0.01% | 781 |
|
|
2019
Q2 | $310K | Buy |
1,125
+15
| +1% | +$3.7K | 0.01% | 736 |
|
|
2019
Q1 | $248K | Buy |
1,110
+4
| +0.4% | +$826 | 0.02% | 528 |
|
|
2018
Q4 | $206K | Sell |
1,106
-108
| -9% | -$22.1K | 0.04% | 439 |
|
|
2018
Q3 | $303K | Buy |
+1,214
| New | +$295K | 0.02% | 445 |
|
Other funds holding IDXX
VCM
VPM
AE Wealth Management's IDXX Position: Q1 2026 in Review
AE Wealth Management reduced its Idexx Laboratories (IDXX) stake by 20% in Q1 2026, selling an estimated $923K and leaving 5,875 shares worth $3.3M. The position accounts for 0.02% of the portfolio, ranked #508.
AE Wealth Management first reported a position in IDXX in Q3 2018 and has held it in 31 quarters since. The position peaked at $22M in Q2 2021. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.
- AE Wealth Management held 5,875 shares of Idexx Laboratories worth $3.3M as of Q1 2026.
- AE Wealth Management sold 1,439 Idexx Laboratories shares in Q1 2026, an estimated $923K.
- Idexx Laboratories made up 0.02% of AE Wealth Management's portfolio in Q1 2026, its #508 holding.
- AE Wealth Management first reported a position in Idexx Laboratories in Q3 2018 and has held it in 31 quarters since.
- AE Wealth Management's Idexx Laboratories position peaked at $22M in Q2 2021.
- 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.
Based on AE Wealth Management's 13F filing for Q1 2026, filed 13 May 2026.